- Home
- SCNX
as 11-21-2024 4:00pm EST
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 14.0M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 18.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.69 - $44.56 | Next Earning Date: | 11-06-2024 |
| Revenue: | N/A | Revenue Growth: | 166.67% |
| Revenue Growth (this year): | 1085.75% | Revenue Growth (next year): | N/A |
Compare SCNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SCNX Scienture Holdings Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.